Wicaksana Bramantya, Yunihastuti Evy, Shatri Hamzah, Pelupessy Dicky C, Koesnoe Sukamto, Djauzi Samsuridjal, Mahdi Haridana Indah Setiawati, Waluyo Dyah Agustina, Djoerban Zubairi, Siddiq Tommy Hariman
Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia-Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia.
Allergy and Clinical Immunology Division, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia/Cipto Mangunkusumo Hospital, Jakarta 10430, Indonesia.
Vaccines (Basel). 2023 Jan 29;11(2):296. doi: 10.3390/vaccines11020296.
People living with HIV (PLHIV) are considered a high-risk population for developing a severe form of COVID-19. Vaccination is still one of the most important modalities in combating the disease due to the lack of an effective treatment. This multicenter study was performed from September to December 2021 with the aim to analyze the intention of PLHIV to receive the COVID-19 vaccination based on an integrated behavior model (IBM) in Indonesia. Of a total of 470 participants, 75.6% of patients were intent to be vaccinated. The model that was designed in this study explains 43.4% of the variance in intention to be vaccinated against COVID-19 in PLHIV (adjusted R = 0.434). Furthermore, the determinants used included instrumental attitude (β = 0.127, < 0.05), subjective norm (β = 0.497, < 0.01), and perceived behavioral control (β = 0.116, < 0.01). This study concluded that an IBM could predict the intention of PLHIV to receive COVID-19 vaccination.
艾滋病毒感染者（PLHIV）被视为感染重症新型冠状病毒肺炎（COVID-19）的高危人群。由于缺乏有效的治疗方法，接种疫苗仍是对抗该疾病最重要的方式之一。这项多中心研究于2021年9月至12月开展，旨在基于印度尼西亚的综合行为模型（IBM）分析艾滋病毒感染者接种COVID-19疫苗的意愿。在总共470名参与者中，75.6%的患者打算接种疫苗。本研究设计的模型解释了艾滋病毒感染者接种COVID-19疫苗意愿差异的43.4%（调整R = 0.434）。此外，所使用的决定因素包括工具性态度（β = 0.127，P < 0.05）、主观规范（β = 0.497，P < 0.01）和感知行为控制（β = 0.116，P < 0.01）。本研究得出结论，综合行为模型可以预测艾滋病毒感染者接种COVID-19疫苗的意愿。
